<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <version>1.0</version>
  <creation_date>2016-05-19 03:12:20 UTC</creation_date>
  <update_date>2026-05-14 19:42:42 UTC</update_date>
  <accession/>
  <common_name>Magnetite</common_name>
  <class>SmallMolecule</class>
  <description>Magnetite is an inorganic compound with the formula Fe and an average molecular weight of 55.84 g/mol. Magnetite belongs to the homogeneous transition metal compounds, a class of homogeneous metal compounds within the inorganic compounds. In biological contexts, it serves as a Lewis base (PMC10853941) and a buffer (PMC4900750).

This compound is found in or released from 62 recorded sources. Within the category of electrical and electronic equipment, it is present in antennas, amplifiers, adjustable resistors, coils, auxiliary devices, and 26 other items. It occurs in building and construction materials such as roofs, floors, ceilings, fencing, ladders, and four other sources. Household items containing magnetite include medals, coins, badges, key rings, and credit card holders. It is also found in household cleaning and consumer products, including bleaching agents, ash trays, cigar cigarettes, non electric simulated smoking devices, other smoking requisites, and six more. Additionally, it is associated with food, food processing, and cookware, specifically in the processing of meats and fish, the preparation of wort and malt, and fermentation processes for beer. Regarding health effects, magnetite is associated with inflammation (PMC4966721).</description>
  <categories/>
  <types/>
  <synonyms>
    <synonym>Fe2+</synonym>
  </synonyms>
  <chemical_formula>Fe</chemical_formula>
  <average_molecular_weight>55.845</average_molecular_weight>
  <monisotopic_moleculate_weight>55.934942133</monisotopic_moleculate_weight>
  <iupac_name>lambda2-iron(2+) ion</iupac_name>
  <traditional_iupac>lambda2-iron(2+) ion</traditional_iupac>
  <cas_registry_number>1309-38-2</cas_registry_number>
  <smiles>[Fe++]</smiles>
  <inchi>InChI=1S/Fe/q+2</inchi>
  <inchikey>CWYNVVGOOAEACU-UHFFFAOYSA-N</inchikey>
  <taxonomy>
    <kingdom>Inorganic compounds</kingdom>
    <super_class>Homogeneous metal compounds</super_class>
    <class>Homogeneous transition metal compounds</class>
    <sub_class/>
    <direct_parent>Homogeneous transition metal compounds</direct_parent>
    <alternate_parents/>
    <substituents>
      <substituent>Homogeneous transition metal</substituent>
    </substituents>
    <molecular_framework/>
    <descriptors>
      <descriptor>a cation</descriptor>
      <descriptor>divalent metal cation</descriptor>
      <descriptor>iron cation</descriptor>
      <descriptor>monoatomic dication</descriptor>
    </descriptors>
  </taxonomy>
  <status>Detected and Not Quantified</status>
  <origin/>
  <cellular_locations/>
  <biofluid_locations/>
  <tissue_locations/>
  <pathways>
    <pathway>
      <name>Carnitine Synthesis</name>
      <smpdb_id>SMP0000465</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Catecholamine Biosynthesis</name>
      <smpdb_id>SMP0000012</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cysteine Metabolism</name>
      <smpdb_id>SMP0000013</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Taurine and Hypotaurine Metabolism</name>
      <smpdb_id>SMP0000021</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phenylalanine and Tyrosine Metabolism</name>
      <smpdb_id>SMP0000008</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pentose Phosphate Pathway</name>
      <smpdb_id>SMP0000031</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Aromatic L-Aminoacid Decarboxylase Deficiency</name>
      <smpdb_id>SMP0000170</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)</name>
      <smpdb_id>SMP0000369</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type 3 (TYRO3)</name>
      <smpdb_id>SMP0000370</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosine Metabolism</name>
      <smpdb_id>SMP0000006</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Inositol Metabolism</name>
      <smpdb_id>SMP0000011</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Porphyrin Metabolism</name>
      <smpdb_id>SMP0000024</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pyrimidine Metabolism</name>
      <smpdb_id>SMP0000046</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tryptophan Metabolism</name>
      <smpdb_id>SMP0000063</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Retinol Metabolism</name>
      <smpdb_id>SMP0000074</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Acute Intermittent Porphyria</name>
      <smpdb_id>SMP0000344</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Porphyria Variegata (PV)</name>
      <smpdb_id>SMP0000346</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Congenital Erythropoietic Porphyria (CEP) or Gunther Disease</name>
      <smpdb_id>SMP0000345</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Alkaptonuria</name>
      <smpdb_id>SMP0000169</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hawkinsinuria</name>
      <smpdb_id>SMP0000190</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type I</name>
      <smpdb_id>SMP0000218</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>beta-Ureidopropionase Deficiency</name>
      <smpdb_id>SMP0000172</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>UMP Synthase Deficiency (Orotic Aciduria)</name>
      <smpdb_id>SMP0000219</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dihydropyrimidinase Deficiency</name>
      <smpdb_id>SMP0000178</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</name>
      <smpdb_id>SMP0000202</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Vitamin A Deficiency</name>
      <smpdb_id>SMP0000336</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hereditary Coproporphyria (HCP)</name>
      <smpdb_id>SMP0000342</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Disulfiram Action Pathway</name>
      <smpdb_id>SMP0000429</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia, Transient, of the Newborn</name>
      <smpdb_id>SMP0000494</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosine Hydroxylase Deficiency</name>
      <smpdb_id>SMP0000497</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dopamine beta-Hydroxylase Deficiency</name>
      <smpdb_id>SMP0000498</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>beta-Mercaptolactate-Cysteine Disulfiduria</name>
      <smpdb_id>SMP0000499</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Glucose-6-phosphate Dehydrogenase Deficiency</name>
      <smpdb_id>SMP0000518</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ribose-5-phosphate Isomerase Deficiency</name>
      <smpdb_id>SMP0000519</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Transaldolase Deficiency</name>
      <smpdb_id>SMP0000520</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Monoamine Oxidase-A Deficiency (MAO-A)</name>
      <smpdb_id>SMP0000533</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cystinosis, Ocular Nonnephropathic</name>
      <smpdb_id>SMP0000722</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>The Oncogenic Action of Succinate</name>
      <smpdb_id>SMP0002292</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>The Oncogenic Action of Fumarate</name>
      <smpdb_id>SMP0002295</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Bloch Pathway (Cholesterol Biosynthesis)</name>
      <smpdb_id>SMP0121057</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Kandutsch-Russell Pathway (Cholesterol Biosynthesis)</name>
      <smpdb_id>SMP0121060</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Succinate Immunometabolism Pathway</name>
      <smpdb_id>SMP0124909</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Duloxetine (SNRI) - Norepinephrine Reuptake Inhibiton</name>
      <smpdb_id>SMP0125000</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Modafinil Action Pathway</name>
      <smpdb_id>SMP0125075</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methyldopa Action Pathway</name>
      <smpdb_id>SMP0125087</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amphetamine Neurological Action Pathway</name>
      <smpdb_id>SMP0125091</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phentermine Action Pathway</name>
      <smpdb_id>SMP0125178</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amitriptyline Norepinephrine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0125187</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methylphenidate Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0125204</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methamphetamine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0125231</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Bupropion Action Pathway</name>
      <smpdb_id>SMP0125268</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Clozapine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0125311</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Immunometabolism Pathway (Bacterial Activation)</name>
      <smpdb_id>SMP0125484</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Immunometabolism Pathway (Viral Activation)</name>
      <smpdb_id>SMP0125488</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Viral Sepsis</name>
      <smpdb_id>SMP0125490</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Bacterial Sepsis</name>
      <smpdb_id>SMP0125493</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Metabolsim and Physiological Effects of 4-Ethylphenylsulfate</name>
      <smpdb_id>SMP0125541</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency</name>
      <smpdb_id>SMP0125583</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps)</name>
      <smpdb_id>SMP0125585</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hyperphenylalaninemia Due to DHPR-Deficiency</name>
      <smpdb_id>SMP0125586</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Segawa Syndrome</name>
      <smpdb_id>SMP0125587</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Sepiapterin Reductase Deficiency</name>
      <smpdb_id>SMP0125588</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hawkinsinuria</name>
      <smpdb_id>SMP0125590</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type I</name>
      <smpdb_id>SMP0125591</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia, Transient, of the Newborn</name>
      <smpdb_id>SMP0125592</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dopamine beta-Hydroxylase Deficiency</name>
      <smpdb_id>SMP0125594</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Monoamine Oxidase-A Deficiency (MAO-A)</name>
      <smpdb_id>SMP0125595</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phenylketonuria</name>
      <smpdb_id>SMP0125602</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)</name>
      <smpdb_id>SMP0125603</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosinemia Type 3 (TYRO3)</name>
      <smpdb_id>SMP0125605</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Aromatic L-Aminoacid Decarboxylase Deficiency</name>
      <smpdb_id>SMP0125610</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tyrosine Hydroxylase Deficiency</name>
      <smpdb_id>SMP0125611</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>beta-Mercaptolactate-Cysteine Disulfiduria</name>
      <smpdb_id>SMP0125612</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cystinosis, Ocular Nonnephropathic</name>
      <smpdb_id>SMP0125613</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Acute Intermittent Porphyria</name>
      <smpdb_id>SMP0125644</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Porphyria Variegata (PV)</name>
      <smpdb_id>SMP0125649</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Congenital Erythropoietic Porphyria (CEP) or Gunther Disease</name>
      <smpdb_id>SMP0125650</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Hereditary Coproporphyria (HCP)</name>
      <smpdb_id>SMP0125651</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Glucose-6-phosphate Dehydrogenase Deficiency</name>
      <smpdb_id>SMP0125653</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ribose-5-phosphate Isomerase Deficiency</name>
      <smpdb_id>SMP0125654</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Transaldolase Deficiency</name>
      <smpdb_id>SMP0125655</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>beta-Ureidopropionase Deficiency</name>
      <smpdb_id>SMP0125716</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>UMP Synthase Deficiency (Orotic Aciduria)</name>
      <smpdb_id>SMP0125717</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dihydropyrimidinase Deficiency</name>
      <smpdb_id>SMP0125719</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)</name>
      <smpdb_id>SMP0125720</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Vitamin A Deficiency</name>
      <smpdb_id>SMP0125788</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Maprotiline Action Pathway</name>
      <smpdb_id>SMP0126344</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Nortriptyline Action Pathway</name>
      <smpdb_id>SMP0126345</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Solriamfetol Action Pathway</name>
      <smpdb_id>SMP0126346</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Trimipramine Action Pathway</name>
      <smpdb_id>SMP0126348</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Desipramine Action Pathway (New)</name>
      <smpdb_id>SMP0126352</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Atomoxetine Action Pathway (New)</name>
      <smpdb_id>SMP0126353</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Clomipramine Action Pathway (New)</name>
      <smpdb_id>SMP0126354</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Doxepin Norepinephrine Reuptake Inhibitor Action Pathway (New)</name>
      <smpdb_id>SMP0126355</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Imipramine Action Pathway (New)</name>
      <smpdb_id>SMP0126359</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Levomilnacipran SNRI - Serotonin Reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126386</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Milnacipran SNRI - Serotonin reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126399</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Vilazodone mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126404</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Desvenlafaxine SNRI - Serotonin reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126423</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Desvenlafaxine SNRI - Norepinephrine reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126425</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Milnacipran SNRI - Norepinephrine reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126429</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Levomilnacipran SNRI - Norepinephrine reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126430</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Fluoxetine - Serotonin reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126435</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Duloxetine SNRI - Serotonin reuptake Inhibition Action Pathway</name>
      <smpdb_id>SMP0126449</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Duloxetine SNRI - Dopamine Norepinephrine Inhibition Action Pathway</name>
      <smpdb_id>SMP0126450</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Aripiprazole Dopamine agonist Action Pathway</name>
      <smpdb_id>SMP0126454</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Aripiprazole Serotonin Agonist Action Pathway</name>
      <smpdb_id>SMP0126456</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ropinirole Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126458</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pramipexole Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126459</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ziprasidone Serotonin Action Action Pathway</name>
      <smpdb_id>SMP0126471</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ziprasidone Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126472</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Thiethylperazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126476</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Thiethylperazine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126477</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Sulpiride Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126479</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Remoxipride Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126480</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Loxapine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126481</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Promazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126483</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Chlorpromazine - Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126485</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Droperidol Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126486</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Chlorpromazine - Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126487</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cladribine Action Pathway</name>
      <smpdb_id>SMP0126490</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Triflupromazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126491</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Clofarabine Action Pathway</name>
      <smpdb_id>SMP0126495</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Fludarabine Action Pathway</name>
      <smpdb_id>SMP0126500</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Fluphenazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126501</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amoxapine SSRI Action Pathway</name>
      <smpdb_id>SMP0126502</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Citalopram Mechanism of Action Action Pathway New</name>
      <smpdb_id>SMP0126506</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Escitalopram Mechanism of Action Action Pathway New</name>
      <smpdb_id>SMP0126509</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Paroxetine Mechanism of Action Action Pathway New</name>
      <smpdb_id>SMP0126510</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Fluvoxamine Mechanism of Action Action Pathway New</name>
      <smpdb_id>SMP0126511</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Sertraline Mechanism of Action Action Pathway New</name>
      <smpdb_id>SMP0126512</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Fluspirilene Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126514</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Flupentixol Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126515</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Flupentixol Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126516</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Mesoridazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126523</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Mesoridazine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126524</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lurasidone Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126526</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lurasidone Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126527</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Perphenazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126530</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amisulpride Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126531</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pimozide Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126532</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cocaine Dopamine-reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126543</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cocaine Norepinephrine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126544</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Triflupromazine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126551</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Thioridazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126559</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Thioridazine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126560</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Trifluoperazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126561</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methotrimeprazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126562</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methylphenidate Norepinephrine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126572</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Acepromazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126576</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Chlorprothixene Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126577</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Zuclopenthixol Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126579</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Thiothixene Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126580</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tiapride Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126581</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Bromopride Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126582</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Acepromazine - Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126586</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Chlorprothixene Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126587</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tiapride Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126590</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Paliperidone Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126592</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Haloperidol Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126593</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Paliperidone Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126597</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Risperidone Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126598</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Risperidone Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126599</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Prochlorperazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126604</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Domperidone Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126605</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Triflupromazine - Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126610</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amitriptyline Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126617</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methamphetamine Norepinephrine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126618</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methamphetamine Serotonin Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126619</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Prochlorperazine - Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126629</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Apomorphine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126633</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pergolide Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126635</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Rotigotine Dopamine Agonist Action Pathway</name>
      <smpdb_id>SMP0126641</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Nelarabine Action Pathway</name>
      <smpdb_id>SMP0126649</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lisuride Dopamine Agonist Action Pathway</name>
      <smpdb_id>SMP0126654</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Epicriptine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126655</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ergoloid mesylate Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126658</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dihydroergocryptine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126659</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cariprazine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126662</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cabergoline Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126670</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tranylcypromine Amine Oxidase Norepinephrine Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126672</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Quinagolide Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126673</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Bromocriptine Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126674</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phenelzine Amine Oxidase Norepinephrine Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126682</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Minaprine Amine oxidase Norepinephrine Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126684</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Moclobemide Amine Oxidase Norepinephrine Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126685</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Isocarboxazid Amine Oxidase Norepinephrine Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126692</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lumateperone SSRI Action Action Pathway</name>
      <smpdb_id>SMP0126693</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lumateperone Dopamine Action Action Pathway</name>
      <smpdb_id>SMP0126694</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lumateperone Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126695</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Safinamide Action Pathway</name>
      <smpdb_id>SMP0126696</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Brexpiprazole Dopamine Agonist Action Pathway</name>
      <smpdb_id>SMP0126698</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Brexpiprazole Serotonin Action Action Pathway</name>
      <smpdb_id>SMP0126699</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pargyline Action Pathway</name>
      <smpdb_id>SMP0126708</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Rasagiline Action Pathway</name>
      <smpdb_id>SMP0126709</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Selegiline Action Pathway</name>
      <smpdb_id>SMP0126719</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phentermine Norepinephrine Reuptake transporter Satiety Action Pathway</name>
      <smpdb_id>SMP0126723</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Agomelatine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126726</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Asenapine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126736</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Asenapine Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126737</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tranylcypromine Amine Oxidase Serotonin Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126744</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Phenelzine Amine Oxidase Serotonin Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126746</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Minaprine Serotonin receptor Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126747</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Moclobemide Amine Oxidase B Serotonin Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126754</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Isocarboxazid Amine Oxidase Serotonin Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126762</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pargyline Amine Oxidase Serotonin Antidepressant Action Pathway</name>
      <smpdb_id>SMP0126766</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ondansetron Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126768</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dosulepin Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126779</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Tropisetron Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126780</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Palonosetron Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126781</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dolasetron Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126782</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Iloperidone Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126784</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Flibanserin Serotonin Action Action Pathway</name>
      <smpdb_id>SMP0126786</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Granisetron Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126787</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Vortioxetine Serotonin Action Action Pathway</name>
      <smpdb_id>SMP0126788</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Quetiapine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126799</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pipotiazine Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126800</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Olanzapine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126804</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Olanzapine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126805</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Pipotiazine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126810</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Metabolism and Physiological Effects of O-Sulfotyrosine</name>
      <smpdb_id>SMP0126811</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Mirtazapine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126817</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Minaprine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126818</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lorpiprazole Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126822</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Quetiapine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126827</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cyproheptadine Serotonin Antagonist Action Pathway</name>
      <smpdb_id>SMP0126842</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Cyclobenzaprine Serotonin antagonist Action Pathway</name>
      <smpdb_id>SMP0126845</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Methysergide Mechanism of Action Action Pathway</name>
      <smpdb_id>SMP0126851</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Neuronal Dopamine Gs Cascade</name>
      <smpdb_id>SMP0126952</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Clozapine Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126963</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Benzatropine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126985</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Mazindol Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126988</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Benzphetamine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126989</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Lisdexamfetamine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126990</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Metoclopramide - Dopamine Antagonist Action Pathway</name>
      <smpdb_id>SMP0126993</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dextroamphetamine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126994</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Vanoxerine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0126997</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Nomifensine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0127002</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Serdexmethylphenidate Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0127003</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Dexmethylphenidate Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0127004</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Sibutramine Dopamine Reuptake Inhibitor Action Pathway</name>
      <smpdb_id>SMP0127006</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amine Oxidase Serotonin</name>
      <smpdb_id>SMP0130456</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Amine Oxidase Norepinephrine</name>
      <smpdb_id>SMP0130460</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Norepinephrine Neurological</name>
      <smpdb_id>SMP0130946</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ferroptosis</name>
      <smpdb_id>SMP0575898</smpdb_id>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Glutaric Acidemia Type I (GA-I)</name>
      <smpdb_id>SMP0658920</smpdb_id>
      <kegg_map_id/>
    </pathway>
  </pathways>
  <state/>
  <appearance/>
  <experimental_properties>
    <property>
      <kind>logp</kind>
      <value>-0.77</value>
    </property>
  </experimental_properties>
  <predicted_properties>
    <property>
      <kind>logp</kind>
      <value>-0.77</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pka_strongest_acidic</kind>
      <value>4.58</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>iupac</kind>
      <value>lambda2-iron(2+) ion</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>average_mass</kind>
      <value>55.845</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>mono_mass</kind>
      <value>55.934942133</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>smiles</kind>
      <value>[Fe++]</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formula</kind>
      <value>Fe</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchi</kind>
      <value>InChI=1S/Fe/q+2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>inchikey</kind>
      <value>CWYNVVGOOAEACU-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polar_surface_area</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>refractivity</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>polarizability</kind>
      <value>1.78</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>rotatable_bond_count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>acceptor_count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>donor_count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>physiological_charge</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>formal_charge</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
  </predicted_properties>
  <route_of_exposure/>
  <mechanism_of_toxicity/>
  <metabolism/>
  <toxicity/>
  <lethaldose/>
  <carcinogenicity/>
  <use_source/>
  <min_risk_level/>
  <health_effects>#&lt;HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f3bbf9aecf8&gt;</health_effects>
  <symptoms/>
  <treatment/>
  <drugbank_id>DB14510</drugbank_id>
  <hmdb_id/>
  <pubchem_compound_id>27284</pubchem_compound_id>
  <chembl_id/>
  <chemspider_id/>
  <kegg_id/>
  <uniprot_id/>
  <omim_id/>
  <chebi_id/>
  <biocyc_id/>
  <ctd_id/>
  <stitch_id/>
  <actor_id/>
  <pdb_id/>
  <wikipidia/>
  <general_references/>
  <targets/>
</compound>
